Celgene's most recent trend suggests a bullish bias. One trading opportunity on Celgene is a Bull Put Spread using a strike $135.00 short put and a strike $125.00 long put offers a potential 11.73% return on risk over the next 35 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $135.00 by expiration. The full premium credit of $1.05 would be kept by the premium seller. The risk of $8.95 would be incurred if the stock dropped below the $125.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Celgene is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Celgene is bullish.
The RSI indicator is above 80 which suggests that the stock is in overbought territory.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Celgene
Short Sellers Hike Bets in Major Biotechs
Wed, 13 Sep 2017 12:55:07 +0000
The August 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
[$$] Celgene Launch to Lift BeiGene
Tue, 12 Sep 2017 17:34:00 +0000
BeiGene (BGNE: Nasdaq) By Maxim Group ($72.64, Sept. 8, 2017) We have updated our BeiGene model to include the launch of BGB-A317 in the U.S. by Celgene, following the close of the transaction. Our model …
Checkpoint Inhibitors Are Hot, and CKPT Has Something in the Oven
Tue, 12 Sep 2017 15:00:00 +0000
NASDAQ:CKPT Checkpoint Therapeutics Inc. (NASDAQ:CKPT) holds a portfolio of targeted anti-cancer and immuno-oncology agents which it is developing for both mono- and combination therapies in solid tumors. …
Who Joins Apple On This List Of New Buys By Top Mutual Funds?
Tue, 12 Sep 2017 13:39:29 +0000
Apple, Celgene, Boeing and UnitedHealth are among the top stocks on this month's list of new buys by top mutual funds.
See what the IHS Markit Score report has to say about Celgene Corp.
Tue, 12 Sep 2017 12:02:21 +0000
Celgene Corp NASDAQ/NGS:CELG
Also on Market Tamer…
Follow Us on Facebook